{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T13:44:03Z","timestamp":1777815843390,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1012066","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000}}],"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00210403"],"award-info":[{"award-number":["RS-2023-00210403"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00301938"],"award-info":[{"award-number":["RS-2023-00301938"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2022R1A2C1010929"],"award-info":[{"award-number":["NRF-2022R1A2C1010929"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010446","name":"Institute for Basic Science","doi-asserted-by":"publisher","award":["IBS-R029-C3"],"award-info":[{"award-number":["IBS-R029-C3"]}],"id":[{"id":"10.13039\/501100010446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Target-mediated drug disposition (TMDD) is a phenomenon characterized by a drug\u2019s high-affinity binding to a target molecule, which significantly influences its pharmacokinetic profile within an organism. The comprehensive TMDD model delineates this interaction, yet it may become overly complex and computationally demanding in the absence of specific concentration data for the target or its complexes. Consequently, simplified TMDD models employing quasi-steady state approximations (QSSAs) have been introduced; however, the precise conditions under which these models yield accurate results require further elucidation. Here, we establish the validity of three simplified TMDD models: the Michaelis-Menten model reduced with the standard QSSA (mTMDD), the QSS model reduced with the total QSSA (qTMDD), and a first-order approximation of the total QSSA (pTMDD). Specifically, we find that mTMDD is applicable only when initial drug concentrations substantially exceed total target concentrations, while qTMDD can be used for all drug concentrations. Notably, pTMDD offers a simpler and faster alternative to qTMDD, with broader applicability than mTMDD. These findings are confirmed with antibody-drug conjugate real-world data. Our findings provide a framework for selecting appropriate simplified TMDD models while ensuring accuracy, potentially enhancing drug development and facilitating safer, more personalized treatments.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1012066","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:28:33Z","timestamp":1713979713000},"page":"e1012066","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Validity conditions of approximations for a target-mediated drug disposition model: A novel first-order approximation and its comparison to other approximations"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6334-8176","authenticated-orcid":true,"given":"Jong Hyuk","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Seon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-2449","authenticated-orcid":true,"given":"Hwi-yeol","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-2172","authenticated-orcid":true,"given":"Jae Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"issue":"3","key":"pcbi.1012066.ref001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.1994.134","article-title":"Pharmacologic target-mediated drug disposition","volume":"56","author":"G. Levy","year":"1994","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"pcbi.1012066.ref002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40262-012-0027-4","article-title":"Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies.","volume":"52","author":"M Dostalek","year":"2013","journal-title":"Clinical Pharmacokinetics."},{"key":"pcbi.1012066.ref003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1014414520282","article-title":"General pharmacokinetic model for drugs exhibiting target-mediated drug disposition","volume":"28","author":"DE Mager","year":"2001","journal-title":"Journal of pharmacokinetics and pharmacodynamics"},{"issue":"1","key":"pcbi.1012066.ref004","first-page":"84","article-title":"The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development","volume":"10","author":"DR Mould","year":"2007","journal-title":"Current Opinion in Drug Discovery and Development"},{"issue":"3","key":"pcbi.1012066.ref005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/jpet.112.191999","article-title":"A model-based approach to predicting the human pharmacokinetics of a monoclonal antibody exhibiting target-mediated drug disposition","volume":"341","author":"KT Luu","year":"2012","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"pcbi.1012066.ref006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1535-7163.MCT-20-0451","article-title":"Antibody co-administration can improve systemic and local distribution of antibody\u2013drug conjugates to increase in vivo efficacy","volume":"20","author":"JF Ponte","year":"2021","journal-title":"Molecular cancer therapeutics"},{"issue":"2","key":"pcbi.1012066.ref007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0025-5564(83)90058-5","article-title":"Quasi-steady-state approximation in the mathematical modeling of biochemical reaction networks","volume":"65","author":"M Schauer","year":"1983","journal-title":"Mathematical biosciences"},{"key":"pcbi.1012066.ref008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/11594240-000000000-00000","article-title":"Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis.","volume":"50","author":"L Sutjandra","year":"2011","journal-title":"Clinical pharmacokinetics."},{"key":"pcbi.1012066.ref009","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fgene.2012.00131","article-title":"Reduction of dynamical biochemical reactions networks in computational biology","volume":"3","author":"O Radulescu","year":"2012","journal-title":"Frontiers in genetics"},{"issue":"5","key":"pcbi.1012066.ref010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10928-008-9102-8","article-title":"Approximations of the target-mediated drug disposition model and identifiability of model parameters","volume":"35","author":"L Gibiansky","year":"2008","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"issue":"7","key":"pcbi.1012066.ref011","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/17425250902992901","article-title":"Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.","volume":"5","author":"L Gibiansky","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"pcbi.1012066.ref012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10928-009-9129-5","article-title":"Gaining insights into the consequences of target-mediated drug disposition of monoclonal antibodies using quasi-steady-state approximations","volume":"36","author":"HP Grimm","year":"2009","journal-title":"Journal of pharmacokinetics and pharmacodynamics"},{"key":"pcbi.1012066.ref013","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11095-005-6650-0","article-title":"Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition","volume":"22","author":"DE Mager","year":"2005","journal-title":"Pharmaceutical research"},{"issue":"3","key":"pcbi.1012066.ref014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1137\/1031091","article-title":"The quasi-steady-state assumption: a case study in perturbation.","volume":"31","author":"LA Segel","year":"1989","journal-title":"SIAM review."},{"issue":"6","key":"pcbi.1012066.ref015","first-page":"324","article-title":"A tutorial on target-mediated drug disposition (TMDD) models.","volume":"4","author":"P Dua","year":"2015","journal-title":"CPT: pharmacometrics & systems pharmacology"},{"issue":"3","key":"pcbi.1012066.ref016","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s11095-011-0615-2","article-title":"Theoretical Considerations of Target-Mediated Drug Disposition Models: Simplifications and Approximations","volume":"29","author":"P. Ma","year":"2011","journal-title":"Pharmaceutical Research"},{"issue":"1","key":"pcbi.1012066.ref017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10928-009-9142-8","article-title":"Selection between Michaelis\u2013Menten and target-mediated drug disposition pharmacokinetic models","volume":"37","author":"X Yan","year":"2009","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"issue":"10","key":"pcbi.1012066.ref018","doi-asserted-by":"crossref","first-page":"e1008258","DOI":"10.1371\/journal.pcbi.1008258","article-title":"Misuse of the Michaelis\u2013Menten rate law for protein interaction networks and its remedy","volume":"16","author":"JK Kim","year":"2020","journal-title":"PLOS Computational Biology"},{"key":"pcbi.1012066.ref019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02458281","article-title":"Extending the quasi-steady state approximation by changing variables","volume":"58","author":"JA Borghans","year":"1996","journal-title":"Bulletin of mathematical biology"},{"issue":"6","key":"pcbi.1012066.ref020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0092-8240(03)00059-4","article-title":"Michaelis\u2013Menten kinetics at high enzyme concentrations","volume":"65","author":"A. Tzafriri","year":"2003","journal-title":"Bulletin of Mathematical Biology"},{"issue":"5","key":"pcbi.1012066.ref021","first-page":"185","article-title":"Pharmacokinetics of pantoprazole in man.","volume":"34","author":"R Huber","year":"1996","journal-title":"Int J Clin Pharm Th"},{"issue":"4","key":"pcbi.1012066.ref022","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/ci400001u","article-title":"Quantitative structure\u2013activity relationship models of clinical pharmacokinetics: clearance and volume of distribution","volume":"53","author":"VK Gombar","year":"2013","journal-title":"Journal of chemical information and modeling"},{"issue":"10","key":"pcbi.1012066.ref023","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s40262-021-01038-6","article-title":"Etomidate and its analogs: a review of pharmacokinetics and pharmacodynamics.","volume":"60","author":"BI Valk","year":"2021","journal-title":"Clinical Pharmacokinetics."},{"issue":"12","key":"pcbi.1012066.ref024","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.drudis.2018.06.010","article-title":"Importance of target-mediated drug disposition for small molecules","volume":"23","author":"DA Smith","year":"2018","journal-title":"Drug Discovery Today"},{"key":"pcbi.1012066.ref025","first-page":"670","article-title":"Prediction of the Pharmacokinetics, Pharmacodynamics, and Efficacy of a Monoclonal Antibody, Using a Physiologically Based Pharmacokinetic FcRn Model.","volume":"5","author":"M Chetty","year":"2014","journal-title":"Front Immunol."},{"issue":"6","key":"pcbi.1012066.ref026","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/cts.12804","article-title":"Beyond the Michaelis-Menten: Accurate Prediction of In Vivo Hepatic Clearance for Drugs With Low KM.","volume":"13","author":"H-m Back","year":"2020","journal-title":"Clinical and Translational Science"},{"issue":"5","key":"pcbi.1012066.ref027","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cpt.2824","article-title":"Beyond the Michaelis-Menten: Accurate Prediction of Drug Interactions Through Cytochrome P450 3A4 Induction","volume":"113","author":"NT Vu","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"pcbi.1012066.ref028","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/s41598-017-17072-z","article-title":"Beyond the Michaelis-Menten equation: Accurate and efficient estimation of enzyme kinetic parameters","volume":"7","author":"B Choi","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"pcbi.1012066.ref029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0895-7177(01)00156-X","article-title":"Enzyme kinetics far from the standard quasi-steady-state and equilibrium approximations","volume":"35","author":"S Schnell","year":"2002","journal-title":"Mathematical and Computer Modelling"},{"issue":"4","key":"pcbi.1012066.ref030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00161-014-0367-4","article-title":"New trends and perspectives in nonlinear intracellular dynamics: one century from Michaelis\u2013Menten paper","volume":"27","author":"AM Bersani","year":"2015","journal-title":"Continuum Mechanics and Thermodynamics"},{"issue":"4","key":"pcbi.1012066.ref031","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jtbi.2006.12.005","article-title":"Quasi-steady-state kinetics at enzyme and substrate concentrations in excess of the Michaelis\u2013Menten constant","volume":"245","author":"A Rami Tzafriri","year":"2007","journal-title":"Journal of Theoretical Biology"},{"issue":"10","key":"pcbi.1012066.ref032","doi-asserted-by":"crossref","first-page":"e1008952","DOI":"10.1371\/journal.pcbi.1008952","article-title":"Universally valid reduction of multiscale stochastic biochemical systems using simple non-elementary propensities","volume":"17","author":"YM Song","year":"2021","journal-title":"PLOS Computational Biology"},{"issue":"10","key":"pcbi.1012066.ref033","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/psp4.12555","article-title":"Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen.","volume":"9","author":"L Ngo","year":"2020","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"issue":"6","key":"pcbi.1012066.ref034","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/cts.12800","article-title":"hIL-7-hyFc, A Long-Acting IL-7, Increased Absolute Lymphocyte Count in Healthy Subjects.","volume":"13","author":"SW Lee","year":"2020","journal-title":"Clin Transl Sci."}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1012066","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T17:44:00Z","timestamp":1715622240000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012066"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1012066","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1012066","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}